S. 527Introduced
Prescription Pricing for the People Act of 2025
Plain-English overview
What this bill does
Require the FTC to report on anticompetitive practices in the pharmaceutical supply chain that may affect prescription drug costs, including PBM conduct and sole source drug complaints
Key points
- Require FTC report
- Require sole source complaint reporting
- Review PBM reimbursement practices
- Review PBM formulary designs
Current status
Where it stands
Status
Introduced
Latest action
2025-04-10 — Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.
Related context
Topics and policy areas
Select a topic to continue exploring related legislation, members, and committees.
Discovery signals
About these signals
Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.
Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.